CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Operating expenses:
Research and development	$ (169)	$ (93)	$ (497)	$ (417)
General and administrative	(151)	(62)	(296)	(194)
Operating loss	(320)	(155)	(793)	(611)
Financial income (expenses), net	(83)	2,174	(130)	(171)
Net profit (loss)	(403)	2,019	(923)	(782)
Non-controlling interests	(137)	(51)	(324)	(228)
Net loss attributable to equity holders of the Company	$ (266)	$ 2,070	$ (599)	$ (554)
Basic net loss per share	$ (0.05)	$ 0.49	$ (0.14)	$ (0.13)
Diluted net loss per share	$ (0.05)	$ 0.49	$ (0.14)	$ (0.13)
Weighted average number of ordinary shares used in computing basic loss per share	4,215,571	4,215,571	4,215,571	4,215,571
Weighted average number of ordinary shares used in computing diluted loss per share	4,215,571	4,215,571	4,215,571	4,215,571